PhD Janez Mravljak

PhD Janez Mravljak
no.: 23419 source: ARIS

researcher – active in research organisation
01 47 69 500
  janez.mravljakat signffa.uni-lj.si
  • English
  • Reading: Functional
  • Writing: Functional
  • Speaking: Functional
  • German
  • Reading: Functional
  • Writing: Basic
  • Speaking: Basic
Edit
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Keywords
Pharmacy, medicinal chemistry
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
385.1
A''
108.01
A'
168.51
A1/2
219.87
CI10
560
CImax
88
h10
13
A1
1.36
A3
1.41
Data for the last 5 years (citations for the last 10 years) on July 25, 2026; Data for score A3 calculation refer to period 2020-2024 (2020, 2021, 2022, 2023, 2024)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 49  738  642  13.1 
Scopus 49  789  697  14.22 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.   Pharmacy  SI University of Ljubljana, Faculty of Pharmacy 2002 
Doctoral degree  Ph. D.   Pharmacy  SI University of Ljubljana, Faculty of Pharmacy 2007 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (120%, RD:20%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry  1/1/2003  Associate professor  Researcher  Full professor 
Research projects Legend
source: ARIS
no. Code Title Period Head of the Last Period
1. J1-70052  Light-Driven Expansion of Chemical Space for Challenging Targets (LUX: BLI-AS-MS)   3/1/2026 - 2/28/2029  PhD Janez Ilaš   1,752 
2. J7-70266  Silver-111-labelled theranostic radiopharmaceuticals for CCK2R-expressing tumours – THERA.SI   3/1/2026 - 2/28/2029  PhD Marko Anderluh   2,051 
3. NK-60002  Development of Dual-Targeting hTOPOII/HDAC Split-and-Mix-PROTAC's   1/1/2026 - 12/31/2028  PhD Janez Ilaš   994 
4. J3-50123  Bacterial Biofilm Formation Inhibitors: A Novel Approach to Combat Antimicrobial Resistance   10/1/2023 - 9/30/2026  PhD Martina Hrast Rambaher   2,741 
5. J3-3079  Bactericidal nanoblades: a proof-of-concept approach for bimodal chemo-mechanical eradication of persistent biofilms   12/1/2021 - 11/30/2025  PhD Stane Pajk   3,031 
6. J1-1709  Strukturni vpogled v mehanizem tvorbe površine bakterije Clostridium difficile   7/1/2019 - 6/30/2023  PhD Dušan Turk   2,176 
7. J7-0337  Formulation and characterization of fuzogenic colloidal nanoparticles for efficient drug delivery into cells   2/1/2008 - 1/30/2011  PhD Marjeta Šentjurc   1,696 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head of the Last Period
1. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2022 - 12/31/2027 PhD Stanislav Gobec   6,224 
2. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2015 - 12/31/2021 PhD Stanislav Gobec   6,908 
3. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2009 - 12/31/2014 PhD Danijel Kikelj   6,761 
4. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2004 - 12/31/2008 PhD Danijel Kikelj   6,723 
Confirmation required
Views history
Favourite